• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在早期肌发生过程中,致癌融合蛋白Pax3-FKHR相对于Pax3具有更高的翻译后稳定性。

The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.

作者信息

Miller Patrick J, Hollenbach Andrew D

机构信息

Department of Genetics, Louisiana State University Health Sciences Center, 533 Bolivar Street, New Orleans, LA 70112, USA.

出版信息

Biochim Biophys Acta. 2007 Oct;1770(10):1450-8. doi: 10.1016/j.bbagen.2007.06.016. Epub 2007 Jul 13.

DOI:10.1016/j.bbagen.2007.06.016
PMID:17698292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2043499/
Abstract

The childhood solid muscle tumor Alveolar Rhabdomyosarcoma (ARMS) is characterized by the t(2;13)(q35;q14) chromosomal translocation, which results in the fusion of two transcription factors important for myogenesis, Pax3 and FKHR (FOX01a). The effects of myogenic differentiation on the stability of FKHR have been well characterized. However, similar studies have yet to be performed on Pax3 or the oncogenic fusion protein Pax3-FKHR. Therefore, we demonstrate in the physiologically relevant mouse primary myoblast system that the expression of Pax3 decreases nearly 95% during the first 24 h of myogenic differentiation. In contrast, there is an aberrant persistence of expression of Pax3-FKHR during this same time period. These differences in protein expression levels do not result from changes on the transcriptional nor the translational level since we observed no concomitant decrease in the levels of Pax3 or Pax3-FKHR mRNA or in the ability of both proteins to be translated. Instead, a pulse-chase analysis determined that Pax3-FKHR has a half-life significantly greater than\ the half-life of wild type Pax3 demonstrating for the first time that Pax3-FKHR has greater post-translational protein stability relative to wild type Pax3 during early myogenic differentiation. Finally, the persistence of expression of Pax3-FKHR prevents the terminal differentiation of primary myoblasts demonstrating a biological consequence of its aberrant expression.

摘要

儿童实体肌肉肿瘤肺泡横纹肌肉瘤(ARMS)的特征是存在t(2;13)(q35;q14)染色体易位,这导致了两个对肌生成很重要的转录因子Pax3和FKHR(FOX01a)的融合。肌源性分化对FKHR稳定性的影响已得到充分表征。然而,尚未对Pax3或致癌融合蛋白Pax3-FKHR进行类似研究。因此,我们在生理相关的小鼠原代成肌细胞系统中证明,在肌源性分化的最初24小时内,Pax3的表达下降了近95%。相比之下,在同一时期,Pax3-FKHR的表达却异常持续。这些蛋白质表达水平的差异并非源于转录或翻译水平的变化,因为我们观察到Pax3或Pax3-FKHR mRNA水平没有相应下降,且这两种蛋白质的翻译能力也未受影响。相反,脉冲追踪分析确定Pax3-FKHR的半衰期明显长于野生型Pax3的半衰期,这首次表明在早期肌源性分化过程中,相对于野生型Pax3,Pax3-FKHR具有更高的翻译后蛋白质稳定性。最后,Pax3-FKHR表达的持续阻止了原代成肌细胞的终末分化,证明了其异常表达的生物学后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/4b50d8d646d4/nihms-31151-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/ad1fa3f3367f/nihms-31151-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/b5783c68eda1/nihms-31151-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/79e1585aa12a/nihms-31151-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/02198fac0c2e/nihms-31151-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/4b50d8d646d4/nihms-31151-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/ad1fa3f3367f/nihms-31151-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/b5783c68eda1/nihms-31151-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/79e1585aa12a/nihms-31151-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/02198fac0c2e/nihms-31151-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6505/2043499/4b50d8d646d4/nihms-31151-f0005.jpg

相似文献

1
The oncogenic fusion protein Pax3-FKHR has a greater post-translational stability relative to Pax3 during early myogenesis.在早期肌发生过程中,致癌融合蛋白Pax3-FKHR相对于Pax3具有更高的翻译后稳定性。
Biochim Biophys Acta. 2007 Oct;1770(10):1450-8. doi: 10.1016/j.bbagen.2007.06.016. Epub 2007 Jul 13.
2
Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma.结构与功能研究的 FKHR-PAX3,一个相互融合基因的 t(2;13) 染色体易位在肺泡横纹肌肉瘤。
PLoS One. 2013 Jun 14;8(6):e68065. doi: 10.1371/journal.pone.0068065. Print 2013.
3
Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation.蛋白激酶 CK2 对丝氨酸 205 的磷酸化作用在早期成肌分化过程中持续存在于 Pax3-FOXO1 上,但不存在于 Pax3 上。
Biochemistry. 2009 Dec 15;48(49):11786-95. doi: 10.1021/bi9012947.
4
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma.肺泡横纹肌肉瘤中涉及PAX和FOX家族成员的基因融合。
Oncogene. 2001 Sep 10;20(40):5736-46. doi: 10.1038/sj.onc.1204599.
5
The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3.在肺泡横纹肌肉瘤中由t(2;13)易位产生的PAX3-FKHR融合蛋白是一种比PAX3更强效的转录激活因子。
Mol Cell Biol. 1995 Mar;15(3):1522-35. doi: 10.1128/MCB.15.3.1522.
6
Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation.鉴定丝氨酸 201 和 209 为 Pax3 磷酸化的位点以及早期成肌分化过程中 Pax3-FOXO1 的磷酸化状态改变。
Int J Biochem Cell Biol. 2011 Jun;43(6):936-45. doi: 10.1016/j.biocel.2011.03.010. Epub 2011 Mar 31.
7
Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells.肾母细胞瘤过表达(NOV/CCN3)基因:PAX3-FKHR 转录靶标中的配对结构域特异性基因,可促进肺泡横纹肌肉瘤细胞的存活和迁移。
Oncogene. 2011 Aug 11;30(32):3549-62. doi: 10.1038/onc.2011.69. Epub 2011 Mar 21.
8
Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.表达PAX3-FKHR的转基因小鼠在肌肉发育方面存在多种缺陷,包括在发育中的神经管中出现异位骨骼肌生成。
Transgenic Res. 2006 Oct;15(5):595-614. doi: 10.1007/s11248-006-9011-9. Epub 2006 Sep 2.
9
The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.肺泡横纹肌肉瘤PAX3/FKHR融合蛋白是一种转录激活因子。
Oncogene. 1995 Aug 3;11(3):545-52.
10
AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cell.AKT 和 PAX3-FKHR 合作抑制肺泡横纹肌肉瘤细胞中的成肌分化阻断。
Cell Cycle. 2012 Mar 1;11(5):895-908. doi: 10.4161/cc.11.5.19346.

引用本文的文献

1
We need to talk-how muscle stem cells communicate.我们需要探讨——肌肉干细胞如何进行通讯。
Front Cell Dev Biol. 2024 Jul 10;12:1378548. doi: 10.3389/fcell.2024.1378548. eCollection 2024.
2
Decoding Oncofusions: Unveiling Mechanisms, Clinical Impact, and Prospects for Personalized Cancer Therapies.解码肿瘤融合基因:揭示机制、临床影响及个性化癌症治疗前景
Cancers (Basel). 2023 Jul 19;15(14):3678. doi: 10.3390/cancers15143678.
3
Requirement for PINCH in skeletal myoblast differentiation.PINCH 在成肌细胞分化中的需求。

本文引用的文献

1
Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion.Rho/ROCK信号通路的失活对于FKHR的核内积累和成肌细胞融合至关重要。
J Biol Chem. 2004 Nov 5;279(45):47311-9. doi: 10.1074/jbc.M403546200. Epub 2004 Aug 22.
2
IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.IκB激酶通过抑制叉头转录因子FOXO3a促进肿瘤发生。
Cell. 2004 Apr 16;117(2):225-37. doi: 10.1016/s0092-8674(04)00302-2.
3
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation.
Cell Tissue Res. 2023 Jan;391(1):205-215. doi: 10.1007/s00441-022-03701-1. Epub 2022 Nov 17.
4
Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma.靶向横纹肌肉瘤中 PAX3-FOXO1 及其调控和转录途径的治疗方法。
Molecules. 2018 Oct 28;23(11):2798. doi: 10.3390/molecules23112798.
5
Acquisition of an oncogenic fusion protein is sufficient to globally alter the landscape of miRNA expression to inhibit myogenic differentiation.获得一种致癌融合蛋白足以全面改变微小RNA(miRNA)表达格局,从而抑制肌源性分化。
Oncotarget. 2017 Jul 29;8(50):87054-87072. doi: 10.18632/oncotarget.19693. eCollection 2017 Oct 20.
6
Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.解旋酶CHD4是肺泡横纹肌肉瘤中PAX3 - FOXO1的一种表观遗传共调节因子。
J Clin Invest. 2016 Nov 1;126(11):4237-4249. doi: 10.1172/JCI85057. Epub 2016 Oct 17.
7
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects.致癌融合蛋白的获得通过诱导非整倍体和克服增殖缺陷,作为初始驱动突变发挥作用。
Oncotarget. 2016 Sep 27;7(39):62814-62835. doi: 10.18632/oncotarget.11716.
8
Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.比较转录组分析揭示致癌融合蛋白PAX3-FOXO1可全面改变mRNA和miRNA以增强成肌细胞侵袭。
Oncogenesis. 2016 Jul 25;5(7):e246. doi: 10.1038/oncsis.2016.53.
9
Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells.正常人类表皮黑素细胞与黑色素瘤细胞中PAX3下游靶基因差异调控的机制。
PLoS One. 2015 Apr 16;10(4):e0124154. doi: 10.1371/journal.pone.0124154. eCollection 2015.
10
Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options.抑制致癌基因 PAX3-FOXO1 的磷酸化可降低肺泡横纹肌肉瘤表型,确定新的治疗选择。
Oncogenesis. 2015 Mar 30;4(3):e145. doi: 10.1038/oncsis.2015.2.
胰岛素诱导的FKHR(Foxo1)磷酸化靶向蛋白酶体降解。
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11285-90. doi: 10.1073/pnas.1934283100. Epub 2003 Sep 17.
4
FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts.原发性小鼠成肌细胞的肌管融合需要FKHR(FOXO1a)。
EMBO J. 2003 Mar 3;22(5):1147-57. doi: 10.1093/emboj/cdg116.
5
Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR.蛋白激酶B和叉头转录因子FKHR对PGC-1启动子活性的调控。
Diabetes. 2003 Mar;52(3):642-9. doi: 10.2337/diabetes.52.3.642.
6
The forkhead transcription factor Foxo1 regulates adipocyte differentiation.叉头转录因子Foxo1调节脂肪细胞分化。
Dev Cell. 2003 Jan;4(1):119-29. doi: 10.1016/s1534-5807(02)00401-x.
7
FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.FOXO蛋白调节肿瘤坏死因子相关凋亡诱导配体的表达。对前列腺癌中PTEN突变的影响。
J Biol Chem. 2002 Dec 6;277(49):47928-37. doi: 10.1074/jbc.M207509200. Epub 2002 Sep 25.
8
The EF-hand calcium-binding protein calmyrin inhibits the transcriptional and DNA-binding activity of Pax3.EF 手型钙结合蛋白钙调素抑制 Pax3 的转录和 DNA 结合活性。
Biochim Biophys Acta. 2002 Apr 12;1574(3):321-8. doi: 10.1016/s0167-4781(02)00230-0.
9
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion.FKHR上的两个新磷酸化位点对其核排除至关重要。
EMBO J. 2002 May 1;21(9):2263-71. doi: 10.1093/emboj/21.9.2263.
10
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.使用实时定量PCR和2(-ΔΔC(T))方法分析相对基因表达数据。
Methods. 2001 Dec;25(4):402-8. doi: 10.1006/meth.2001.1262.